Simbec-Orion

Simbec-Orion and biotx.ai launch strategic partnership to de-risk early-stage drug development with AI supported clinical trial design

Veröffentlicht: 07.08.2025 um 18:08 Uhr, prnewswire.co.uk

Simbec-Orion Washington United Kingdom

en | boerse | 67932647 |